Michael Klichinsky

Michael Klichinsky

Company: Carisma Therapeutics

Job title: Co-Founder & VP, Discovery


Mike is a co-inventor of the CAR Macrophage technology and a scientific co-founder of Carisma Therapeutics Inc. In his role as VP of Discovery Research, he oversees the research & discovery efforts of the company.

Mike developed CAR Macrophages during his doctoral thesis under the co-mentorship of Saar Gill and Carl June at the University of Pennsylvania. Michael’s scientific expertise is in the intersection of immunology, synthetic biology, cancer immunotherapy, and translational pharmacology.

Mike previously earned a Doctor of Pharmacy degree from the University of Sciences in Philadelphia, and a PhD in Pharmacology from the University of Pennsylvania.


Development of CT-0508, a First-in-Class CAR-M, For Solid Tumor Immunotherapy 12:00 pm

Key rationale for development of monocyte/ macrophage based therapeutics Overview of Carisma’s proprietary engineered mono/macrophage cell therapy technology CT-0508: clinical trial in progress updateRead more

day: Clinical Development - Day 1 am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.